5th Dec 2022 11:14
(Alliance News) - Ondine Biomedical Inc on Monday said it has received funding towards the development of a food-safe photodisinfection method, to be used in Canada's meat packing industry.
Ondine Biomedical is a Vancouver, Canada-based life sciences company, which specialises in exploring and developing photodisinfection therapies. In addition to nasal photodisinfection, products include therapies for a variety of medical indications, such as chronic sinusitis and ventilator-associated pneumonia.
The company has received funding of up to USD735,000 from Agriculture & Agri-Food Canada, to be used to develop a prototype of its novel photodisinfection application for use in food production.
"Approximately 3.5 billion kilograms of poultry and meat are wasted every year globally, with a significant portion of this due to microbial spoilage. The related costs of beef spoilage alone in Canada are estimated at USD200 million per year," said President Nicolas Loebel.
"Recognizing the impact of antibiotic resistance in the meat packing industry, we realized that we could deploy the same technology in food safety - eliminating tough, food-borne pathogens which can undermine the health and safety of all Canadians. We are delighted to be recognized by Agriculture and Agri-Food Canada as a key contributor in their fight against this problem and believe we are uniquely positioned to develop an effective solution"
Ondine shares were trading 3.4% lower at 24.15 pence each in London on Monday morning.
By Holly Beveridge; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Ondine Biomed